AQST - Aquestive Therapeutics Inc
IEX Last Trade
4.52
0.120 2.655%
Share volume: 892,930
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$4.40
0.12
2.73%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-02 | 2022-11-01 | 2023-03-31 | 2023-05-02 | 2023-08-07 | 2023-11-06 | 2024-03-05 | 2024-05-07 | |
| Total revenue | 13.265 M | 11.463 M | 10.682 M | 11.134 M | 13.241 M | 13.002 M | 13.206 M | 12.053 M | |
| Cost of revenue | 5.242 M | 4.625 M | 5.305 M | 4.737 M | 6.617 M | 4.798 M | 4.679 M | 4.389 M | |
| Gross profit | 8.023 M | 6.838 M | 5.377 M | 6.397 M | 6.624 M | 8.204 M | 8.527 M | 7.664 M | |
| -14.77% | -21.37% | 18.97% | 3.55% | 23.85% | 3.94% | -10.12% | |||
| Operating expenses | 20.785 M | 15.691 M | 16.090 M | 11.002 M | 10.833 M | 10.581 M | 12.438 M | 16.621 M | |
| Selling general and admin | 15.587 M | 12.459 M | 11.812 M | 7.455 M | 7.360 M | 7.385 M | 9.550 M | 10.689 M | |
| Research and development | 5.198 M | 3.232 M | 4.278 M | 3.547 M | 3.473 M | 3.196 M | 2.888 M | 5.932 M | |
| Total expenses | 26.027 M | 20.316 M | 21.395 M | 15.739 M | 17.450 M | 15.379 M | 17.117 M | 21.010 M | |
| -21.94% | 5.31% | -26.44% | 10.87% | -11.87% | 11.30% | 22.74% | |||
| Operating income | -12.762 M | -8.853 M | -10.713 M | -4.605 M | -4.209 M | -2.377 M | -3.911 M | -8.957 M | |
| Ebit | -12.762 M | -8.853 M | -10.713 M | -4.605 M | -4.209 M | -2.377 M | -3.911 M | -8.957 M | |
| Pretax income | -16.302 M | -12.536 M | -12.352 M | 8.068 M | -5.508 M | -2.175 M | -8.010 M | -12.828 M | |
| -23.10% | -1.47% | -165.32% | -168.27% | -60.51% | 268.28% | 60.15% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 284.000 K | -140.000 K | 101.000 K | 0.000 | |
| Net income basic | -16.302 M | -12.536 M | -12.352 M | 8.068 M | -5.792 M | -2.035 M | -8.111 M | -12.828 M | |
| 23.10% | 1.47% | 165.32% | -171.79% | 64.87% | -298.57% | -58.16% | |||
| Net income | -16.302 M | -12.536 M | -12.352 M | 8.068 M | -5.792 M | -2.035 M | -8.111 M | -12.828 M | |
| 23.10% | 1.47% | 165.32% | -171.79% | 64.87% | -298.57% | -58.16% |